Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
Steven J. Kernis, MD*,*,
Kishore J. Harjai, MD, FACC*,
Gregg W. Stone, MD, FACC ,
Lorelei L. Grines, PhD*,
Judith A. Boura, MS*,
William W. O'Neill, MD, FACC* and
Cindy L. Grines, MD, FACC*
* Cardiology Division, William Beaumont Hospital, Royal Oak, Michigan, USA
Cardiology Division, Lenox Hill Hospital, New York, New York, USA

View larger version (29K):
[in a new window]
|
Figure 1 Six-month clinical outcomes of study groups. EF = ejection fraction; MACE = major adverse cardiac events; MVD = multi-vessel disease; SVD = single-vessel disease.
|
|

View larger version (29K):
[in a new window]
|
Figure 2 Six-month mortality survival curves between study groups. Abbreviations as in Figure 1.
|
|

View larger version (21K):
[in a new window]
|
Figure 3 Multivariate predictors of six-month mortality. CI = confidence interval.
|
|
|